首页> 外国专利> METHOD CORRECTION endothelial dysfunction preparations 'ETOKSIDOL' IN L-NAME DEFICIT INDUCED NITRIC OXIDE

METHOD CORRECTION endothelial dysfunction preparations 'ETOKSIDOL' IN L-NAME DEFICIT INDUCED NITRIC OXIDE

机译:方法纠正左名缺乏引起的一氧化氮中的内皮功能障碍制剂“ ETOKSIDOL”

摘要

FIELD: medicine.;SUBSTANCE: in order to correct endothelial dysfunction white male rats of Wistar line have endothelial dysfunctions modelled by intro-peritoneum introduction of N-nitro-L-arginine methyl ether in dose 25 mg/kg daily, for seven days. Degree of dysfunction development is estimated by ratio of indices of endothelium-independent and endothelium-dependent vasodilation. Correction of endothelial dysfunction is carried out by intra-peritoneum introduction of medicine "Etoxydol" in dose 25 mg/kg one time per day, for 7 days in the morning.;EFFECT: correction of endothelial dysfunction by novel derivative of 3-oxypyridine in specially developed for this purpose dose and mode of medication introduction.;2 tbl, 1 ex
机译:领域:医学;目的:为了纠正内皮功能障碍,Wistar系的白色雄性大鼠具有以每天25 mg / kg的剂量腹膜内引入N-硝基-L-精氨酸甲基醚为模型,持续7天的内皮功能障碍。通过内皮依赖性和内皮依赖性血管舒张指数的比率来估计功能障碍的发展程度。内皮功能障碍的纠正是通过每天一次一次腹膜内引入剂量为25 mg / kg的药物“ Etoxydol”进行的,每天早上7天;效果:用3-氧吡啶的新型衍生物纠正内皮功能障碍。为此目的专门开发的剂量和方式。2tbl,1 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号